| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ATHORACSUR.2006.08.046 |
| P698 | PubMed publication ID | 17257962 |
| P2093 | author name string | Ping Yang | |
| Mark S Allen | |||
| Stephen D Cassivi | |||
| Claude Deschamps | |||
| Francis C Nichols | |||
| Hiroshi Sugimura | |||
| Brent A Williams | |||
| Peter C Pairolero | |||
| P433 | issue | 2 | |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 409-17; discussioin 417-8 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | The Annals of Thoracic Surgery | Q1939819 |
| P1476 | title | Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection | |
| P478 | volume | 83 |
| Q36345601 | 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients |
| Q58083112 | A rare case of squamous cell carcinoma lung with multiple locoregional recurrences and histological transformation |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q89879707 | Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions |
| Q35825840 | An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers |
| Q99603870 | Characteristics of surgically resected non-small cell lung cancer patients with post-recurrence cure |
| Q35042175 | Clinicopathological features and outcome of gastric metastases from primary lung cancer: A case report and systematic review |
| Q35903931 | Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer |
| Q35996056 | Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer |
| Q52715754 | Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer. |
| Q40681590 | Detection of Recurrence Patterns After Wedge Resection for Early Stage Lung Cancer: Rationale for Radiologic Follow-Up |
| Q41857918 | Diagnosis, staging and treatment of patients with non-small cell lung cancer for the surgeon. |
| Q34635787 | Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer. |
| Q36666814 | Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas |
| Q93182436 | EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma |
| Q89400755 | Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection |
| Q52806184 | Editorial on "Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is 'cured' from postoperative recurrence?" |
| Q34135295 | Epidemiology of lung cancer prognosis: quantity and quality of life |
| Q38827255 | Exercise Training for Patients Pre- and Postsurgically Treated for Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis |
| Q36898402 | Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma |
| Q36055064 | Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer |
| Q55172381 | Gene methylation in liquid biopsy and risk of recurrence in lung cancer. |
| Q36619063 | Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells |
| Q35068234 | High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer |
| Q37458015 | High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non-small-cell lung cancer |
| Q34066609 | Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service |
| Q92306110 | Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better? |
| Q40671870 | Imaging surveillance and survival for surgically resected non-small-cell lung cancer |
| Q41878129 | Immunotherapy as a strategy for the treatment of non-small-cell lung cancer |
| Q30275205 | Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study |
| Q38622807 | Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resection |
| Q33873206 | Impact of the Bim Deletion Polymorphism on Survival Among Patients With Completely Resected Non-Small-Cell Lung Carcinoma |
| Q42384614 | Improving post-resection risk stratification in non-small cell lung cancer: 'wit, whither wander you?' |
| Q35078797 | Inhibition of miR-191 contributes to radiation-resistance of two lung cancer cell lines by altering autophagy activity |
| Q37033306 | Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer |
| Q41151899 | Integrated care for resected early stage lung cancer: innovations and exploring patient needs |
| Q37002744 | Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer |
| Q30411297 | Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes |
| Q61448599 | Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome |
| Q33583923 | Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer |
| Q36817059 | Lung cancer prognosis before and after recurrence in a population-based setting |
| Q27014375 | Lung cancer vaccines |
| Q37643548 | Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer. |
| Q54541339 | Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. |
| Q99582819 | PD-L1 as a prognostic biomarker in surgically resectable non-small cell lung cancer: a meta-analysis |
| Q37201454 | PET/CT vs. non-contrast CT alone for surveillance 1-year post lobectomy for stage I non-small-cell lung cancer |
| Q40727371 | Pattern of Imaging after Lung Cancer Resection. 1992-2005. |
| Q89497111 | Patterns and risks of postoperative recurrence in completely resected EGFR-mutant non-small cell lung cancer: prognostic significance of routine immunohistochemical markers |
| Q37088999 | Performance of an item response theory-based computer adaptive test in identifying functional decline |
| Q41673451 | Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer |
| Q36543892 | Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy |
| Q37567804 | Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status |
| Q36540289 | Prediction and prognostic factors of post-recurrence survival in recurred patients with early-stage NSCLC who underwent complete resection |
| Q34633138 | Predictors of imaging surveillance for surgically treated early-stage lung cancer |
| Q36682970 | Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes |
| Q42783628 | Prognosis of recurrence after complete resection in early-stage non-small cell lung cancer |
| Q37652622 | Prognosis of recurrent non-small cell lung cancer following complete resection |
| Q38067307 | Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer. |
| Q85119139 | Prognostic impact of local treatment against postoperative oligometastases in non‐small cell lung cancer |
| Q35621522 | Quality of life and symptom burden among long-term lung cancer survivors |
| Q84801903 | Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area |
| Q38806218 | Real-Time Reverse-Transcription Quantitative Polymerase Chain Reaction Assay Is a Feasible Method for the Relative Quantification of Heregulin Expression in Non-Small Cell Lung Cancer Tissue |
| Q35052543 | Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer |
| Q47353436 | Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer |
| Q90697953 | Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients |
| Q100725157 | Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma |
| Q37701727 | Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma |
| Q43537012 | Stage II-IV lung cancer cases with lymphovascular invasion relapse within 2 years after surgery |
| Q36369879 | Standardization and Optimization of Intraoperative Molecular Imaging for Identifying Primary Pulmonary Adenocarcinomas. |
| Q37972092 | Surgical management of adrenal metastases |
| Q36503157 | Surgical resection of solitary omental metastasis from non-small cell lung cancer: Report of three cases |
| Q39256220 | Surgical treatment for gastrointestinal metastasis of non-small-cell lung cancer after pulmonary resection |
| Q47099923 | Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy |
| Q41522621 | Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma |
| Q38715187 | Synthetic Biomaterials from Metabolically Derived Synthons |
| Q35679806 | TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival |
| Q39458588 | TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer. |
| Q37699454 | Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma |
| Q36326572 | Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality |
| Q54313517 | The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor. |
| Q96304930 | The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy |
| Q36055418 | The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors |
| Q27011293 | Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer |
| Q36292310 | Transbronchial and transesophageal fine-needle aspiration using a single ultrasound bronchoscope in the diagnosis of locoregional recurrence of surgically-treated lung cancer |
| Q37597299 | Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma. |
| Q37870836 | γδ T-cell immunotherapy for lung cancer. |
Search more.